Colorectal Cancer Not MSI-H or MMR-deficient
1 clinical trials · Condition
◉ Watch Colorectal Cancer Not MSI-H or MMR-deficient
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953) | Institut Bergonié | 2018-05-04 |
Track Colorectal Cancer Not MSI-H or MMR-deficient automatically
Every clearance here is in the API, with alerts when new ones post.